ClinicalTrials.gg
Sign In
Status unknownNCT04199377ALLCCPUpdated Dec 13, 2019

Retrospective Evaluation of Clinical and Functional Results and Survivorship of Total Knee Replacement and Total Hip Replacement, Both Isolated or Combined.

An interventional study of HIP KNEE REPLACEMENT in HIP REPLACEMENT and KNEE REPLACEMENT, sponsored by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio. Status unknown at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-12-13.

Sponsored by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Dec 2019), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
500
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Retrospective evaluation of clinical and functional results and survivorship of total knee replacement and total hip replacement, both isolated or combined.

Read the detailed description

Retrospective evaluation of clinical and functional results and survivorship of total knee replacement and total hip replacement, both isolated or combined.

Evaluation performed 1, 2, 5, 10 and 15 years after surgery

02

Conditions studied

  • HIP REPLACEMENT
  • KNEE REPLACEMENT
03

In context

Lead sponsor

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio is the lead sponsor of 160 studies on the registry; 59 are open to participants now.

Browse I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥ 18 years
  • Patients underwent total knee or hip replacement, both isolated or combined with other surgical procedures

Exclusion criteria

Exclusion criteria

- Patients underwent other types of knee or hip replacement

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
500 participants (estimated)

Study arms

  • Experimental
    hip or knee replacement

    total hip or knee replacement

    Procedure: HIP KNEE REPLACEMENT

Interventions

  • ProcedureHIP KNEE REPLACEMENT

    HIP KNEE REPLACEMENT

06

What researchers measure

Primary outcomes

  1. HARRIS HIP SCORE

    scale range: 0-100; excellent results: 80-100

    Time frame: 10 years

  2. KNEE SOCIETY SCORE

    scale range: 0-100; excellent results: 80-100

    Time frame: 10 years

  3. HARRIS HIP SCORE

    scale range: 0-100; excellent results: 80-100

    Time frame: 5 years

  4. KNEE SOCIETY SCORE

    scale range: 0-100; excellent results: 80-100

    Time frame: 5 years

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Oct 2017 (actual). Primary completion is estimated for Jan 2020, 26 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 27, 2017
First posted
Dec 13, 2019
StartActual
Oct 20, 2017
Primary completionEst.
Jan 1, 2020
CompletionEst.
Jan 1, 2021
Last update
Dec 13, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 13, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04199377
Lead sponsor
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Responsible party
Sponsor
First posted
Dec 13, 2019
Start date
Oct 20, 2017
Primary completion
Jan 1, 2020 (estimated)
Completion
Jan 1, 2021 (estimated)
Last update
Dec 13, 2019

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio →

Start the discussion